Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

FxtmVideos

Latest Market Research Articles

Cooling Commodity: Brent Oil wary of OPEC+ shock
Han Tan

30 November @ 04:23

By Han Tan, Market Analyst

Cooling Commodity: Brent Oil wary of OPEC+ shock
Oil prices are starting the new week by trimming more of their November gains, amid reports that OPEC+ members are struggling to agree whether or not to delay its planned supply hike in January. The group of major Oil producers held informal talks over the weekend, with no positive breakthrough... Read full post
Week in review: Upbeat mood, Bitcoin slides, Gold meltdown
Lukman Otunuga

27 November @ 18:12

By Lukman Otunuga, Research Analyst

Week in review: Upbeat mood, Bitcoin slides, Gold meltdown
It has been an eventful week defined by COVID-19, vaccine optimism and volatility not only in the commodity arena but cryptocurrency space!   Straight across the Atlantic, roughly a quarter of all U.S. coronavirus cases since the start of the pandemic was reported in November.... Read full post
Risk sentiment on thinning ice?
Han Tan

27 November @ 04:56

By Han Tan, Market Analyst

Risk sentiment on thinning ice?
Asian stocks are mixed while US and European equity futures are slightly lower, as risk appetite attempts to overcome concerns over the efficacy of AstraZeneca’s Covid-19 vaccine. Investor confidence had been shaken after learning about the manufacturing error in the drugmaker’s vaccine trials,... Read full post
Scroll Top